Influence of Apoptosis and Cell Cycle Regulator Proteins on Chemotherapy Response and Survival in Stage IIIA/IIIB NSCLC Patients
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference31 articles.
1. Revision in the International System for staging Lung Cancer;Mountain;Chest,1997
2. A randomised trial comparing perioperative chemotherapy and surgery with surgery alone in resectable IIIA NSCLC;Roth;J Natl Cancer Inst,1994
3. A randomized trial comparing pre operative chemotherapy plus surgery with surgery alone in patients with non small cell lung cancer;Rosell;NEJM,1994
4. CHEST guidelines for treatment of stage IIIA non small cell lung cancer;Chest,2003
5. Preoperative chemotherapy followed by surgery compared with primary surgery in resected stage I (except T1N0), II, and IIIA NSCLC;Depierre;J Clin Oncol,2002
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy;Journal of Cancer Research and Clinical Oncology;2020-04-30
2. Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients;Respiratory Research;2018-08-13
3. Serum SP 70 is a sensitive predictor of chemotherapy response in patients with advanced nonsmall cell lung cancer;Cancer Medicine;2018-05-16
4. Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11;Oncotarget;2015-03-26
5. Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer;BMC Cancer;2014-10-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3